Copenhagen University Hospital
LEO Pharma elects Henriette Mersebach to the Board of Directors
Mersebach previously held senior leadership positions at ALK-Abelló and Novo Nordisk
LEO Pharma acquires rights for dersimelagon from Tanabe Pharma
The company will pay $435m in up front and near-term milestone payments
LEO Pharma and Allergy UK launch ‘Don’t Ignore’ chronic hand eczema campaign
The campaign aims to improve awareness and understanding of the condition
LEO Pharma to acquire Replay gene therapy platform
The acquisition will advance innovation for patients with rare skin diseases
Matt Ferriday announced as General Manager for LEO Pharma UK
Ferriday most recently held senior leadership roles at Ipsen Biopharma
Almirall celebrates new offices in China to advance innovation in dermatology
The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners
LEO Pharma’s Anzupgo cream progresses to phase 3 trial for lichen sclerosus
There are currently no approved treatments specifically indicated for LS in the US or Europe
LEO Pharma receives NICE approval for chronic hand eczema cream
The cream can now be prescribed for patients when topical corticosteroids have not worked or are not suitable
Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education
UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...
Almirall and Absci expand AI dermatological drug discovery partnership
The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target
Apogee Therapeutics’ atopic dermatitis candidate shows promise in phase 2 study
The inflammatory skin condition affects over 26 million people in the US
LEO’s Anzupgo granted FDA approval to treat moderate-to-severe chronic hand eczema
The cream is now the first treatment approved by the regulator specifically for this patient population